A new drug developed by scientists at the Florey Institute of Neuroscience, and the School of Chemistry and Bio21 Institute at the University of Melbourne has dramatically improved clinical and cognitive symptoms of motor neurone disease, also called amyotrophic lateral sclerosis.
Motor neurone disease is a progressive, fatal neurodegenerative disease. Its key hallmark is the death of the brain cells that control muscle movements. This results in muscle weakness and eventually paralysis.
Patients usually die of respiratory failure within three years of diagnosis, and there are no treatments or disease-modifying therapies available.
In this dose-finding trial involving 32 patients, the group given the highest amount of the CuATSM compound showed improved lung function and cognitive ability, compared to the predicted declines observed in standard-of-care patients.
Further, treated patients showed a much slower overall disease progression as measured by a global disability score.
The clinical trial was led by Professor Dominic Rowe at Macquarie University, and Associate Professor Susan Mathers at Calvary Health Care Bethlehem, and sponsored by Collaborative Medicinal Development Pty Ltd with support from FightMND.
Professor Ashley Bush, Chief Scientific Officer of Collaborative Medicinal Development and director of the Melbourne Dementia Research Centre, said “This is the first human evidence for a disease-modifying drug for motor neurone disease. It is a huge breakthrough, and we look forward to confirming the positive results in a larger study soon.”
Associate Professor Kevin Barnham of the Florey, Associate Professor Anthony White at the Queensland Institute of Medical Research, and Professor Paul Donnelly and Associate Professor Peter Crouch from the University of Melbourne, developed and tested CuATSM over a 15-year period.
After showing its therapeutic potential for motor neurone disease in pre-clinical models, the researchers founded a company and licenced the compound to Collaborative Medicinal Development, to take the drug into human studies.
Professor Donnelly said, “It is gratifying to see such promising results made possible by collaborative fundamental research at the interface between chemistry and biology.”
The Latest on: Motor neurone disease
via Google News
The Latest on: Motor neurone disease
- Ben-Gurion University Introduces Novel AI Platform for Monitoring and Predicting ALS Progression on February 19, 2019 at 3:00 am
ALS is a motor neuron disease that almost invariably progresses with time. Research and drug development of this condition are complicated by the heterogeneity of the ALS population leading to variabi... […]
- Motor Neuron Disease: Can Dietary Supplements Help? on February 18, 2019 at 4:22 am
Modifying the diet and nutritional intake of individuals with motor neuron disease (MND) is paramount in managing the disorder. Symptoms of muscle weakness and stiffness of the muscles of the hands, a... […]
- Are you at high risk of developing motor neuron diseases? Strike these yoga poses on February 18, 2019 at 3:25 am
Motor neuron diseases are a group of progressive neurological conditions ... Unfortunately, there is no cure of this disease till now. Therefore, it is extremely important for people to follow the rec... […]
- Statins could protect against motor neuron disease on February 17, 2019 at 5:23 pm
High cholesterol has been found to be a possible risk factor for the development of motor neuron disease (MND), according to a large study of genetic data. High cholesterol has been found to be a poss... […]
- Statins could protect against motor neurone disease, scientists suggest on February 15, 2019 at 4:24 am
High cholesterol could be a risk factor in development of motor neurone disease, according to a study of genetic data by UK scientists. A team led by the Queen Mary University of London, in ... […]
- Statins to Protect Against Motor Neuron Disease on February 14, 2019 at 11:57 pm
High cholesterol could increase the risk of development of motor neuron disease (MND), according to a large study of genetic data led in the UK by Queen Mary University of London, in collaboration wit... […]
- Statins could protect against motor neurone disease on February 14, 2019 at 7:00 am
High cholesterol has been found to be a possible risk factor for the development of motor neurone disease (MND), according to a large study of genetic data led in the UK by Queen Mary University ... […]
- Scientists identify new disrupted pathway in motor neurone disease on February 13, 2019 at 5:12 am
Researchers at the University of Sheffield have identified a new pathway that is disrupted in motor neurone disease (MND), a discovery which could pave the way for new treatments. The scientists ... […]
- Living with motor neurone disease: ‘I hoped I was suffering PTSD’ on February 11, 2019 at 11:18 pm
As a nation of raconteurs, most of us love to talk – about the weather, the state of the world or what we did last weekend. But for a small sector of the population, having a chat isn’t an option as, ... […]
- Changemakers: Unlocking technology for people with motor neurone disease on February 11, 2019 at 6:45 am
It took a neck brace, internet strangers and being bored at work, but Julius Sweetland changed thousands of lives. The 35-year-old’s software OptiKey lets people with motor neurone disease use compute... […]
via Bing News